Refining actionable HER2 alterations in lung cancers through next generation sequencing (NGS) Meeting Abstract


Authors: Xu, C.; Myers, M.; Buonocore, D. J.; Razavi, P.; Shen, R.; Lai, W. C. V.; Smyth, L. M.; Zheng, T.; Ni, A.; Solit, D. B.; Zehir, A.; Brzostowski, E. B.; Hellmann, M. D.; Drilon, A. E.; Rudin, C. M.; Berger, M. F.; Ladanyi, M.; Kris, M. G.; Li, B. T.; Arcila, M. E.
Abstract Title: Refining actionable HER2 alterations in lung cancers through next generation sequencing (NGS)
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Language: English
ACCESSION: WOS:000442916007394
DOI: 10.1200/JCO.2018.36.15_suppl.e24181
PROVIDER: wos
Notes: Meeting Abstract: e24181 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Solit
    781 Solit
  2. Ronglai Shen
    206 Shen
  3. Marc Ladanyi
    1332 Ladanyi
  4. Ahmet Zehir
    345 Zehir
  5. Michael Forman Berger
    769 Berger
  6. Maria Eugenia Arcila
    669 Arcila
  7. Mark Kris
    872 Kris
  8. Alexander Edward Drilon
    636 Drilon
  9. Matthew David Hellmann
    412 Hellmann
  10. Tao Zheng
    10 Zheng
  11. Charles Rudin
    495 Rudin
  12. Pedram Razavi
    184 Razavi
  13. Bob Tingkan Li
    279 Li
  14. Lillian   Smyth
    42 Smyth
  15. Ai   Ni
    99 Ni
  16. Wei-Chu Victoria Lai
    59 Lai
  17. Chongrui Xu
    8 Xu
  18. Mackenzie Myers
    15 Myers